Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy

Liquid biopsy, based on the circulating tumor cells (CTCs) and cell-free nucleic acids has potential applications at multiple points throughout the natural course of cancer, from diagnosis to follow-up. The advantages of doing ctDNA assessment vs. tissue-based genomic profile are the minimal procedu...

Full description

Bibliographic Details
Main Authors: Alessia Cimadamore, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Cancers
Subjects:
renal cell carcinoma
circulating DNA
CTC
diagnosis
follow-up
genetic alteration
target therapy
Online Access:https://www.mdpi.com/2072-6694/11/2/196

Internet

https://www.mdpi.com/2072-6694/11/2/196

Similar Items